SummitTX Capital L.P. Purchases New Stake in Align Technology, Inc. $ALGN

SummitTX Capital L.P. acquired a new position in Align Technology, Inc. (NASDAQ:ALGN) in the 1st quarter, HoldingsChannel reports. The firm acquired 9,507 shares of the medical equipment provider’s stock, valued at approximately $1,630,000.

Several other institutional investors have also recently made changes to their positions in ALGN. Capital International Investors raised its holdings in shares of Align Technology by 52.2% in the fourth quarter. Capital International Investors now owns 4,643,221 shares of the medical equipment provider’s stock valued at $725,039,000 after purchasing an additional 1,592,848 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Align Technology by 37.4% in the 3rd quarter. Invesco Ltd. now owns 1,497,535 shares of the medical equipment provider’s stock worth $187,521,000 after buying an additional 407,559 shares during the last quarter. Capital World Investors boosted its stake in shares of Align Technology by 13.2% in the 4th quarter. Capital World Investors now owns 1,490,503 shares of the medical equipment provider’s stock worth $232,742,000 after buying an additional 173,641 shares during the last quarter. Bank of America Corp DE increased its position in shares of Align Technology by 72.0% during the third quarter. Bank of America Corp DE now owns 1,353,125 shares of the medical equipment provider’s stock valued at $169,438,000 after acquiring an additional 566,488 shares during the last quarter. Finally, Ruane Cunniff & Goldfarb L.P. bought a new position in Align Technology in the 4th quarter valued at $190,899,000. Institutional investors own 88.43% of the company’s stock.

Trending Headlines about Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations: Align reported adjusted earnings of $2.64 per share, ahead of analysts’ approximately $2.62 consensus estimate and up from $2.49 a year earlier. Revenue increased 4.3% year over year to $1.056 billion, also topping estimates near $1.05 billion. Align Technology Announces Second Quarter 2026 Financial Results
• Positive Sentiment: Board and strategic overhaul: Align will add three independent directors and conduct an operating review after discussions with Elliott. The changes could improve corporate governance, sharpen execution and increase the prospect of shareholder-friendly actions. Align Technology to overhaul board following engagement with Elliott
• Neutral Sentiment: Third-quarter outlook was broadly in line: Align issued revenue guidance of approximately $1.0 billion, consistent with consensus expectations. The available guidance did not include a specific EPS figure, limiting visibility into near-term profitability.
• Neutral Sentiment: Analyst coverage remains constructive, with the reported average price target of $206.07 above the stock’s recent trading level, though price targets are subject to revision after the earnings release. Align Technology Receives Average Price Target from Analysts
• Negative Sentiment: Growth remains moderate: Although revenue and earnings improved, the 4.3% annual revenue increase and roughly $1.0 billion third-quarter outlook may not signal a sharp acceleration. Investors will likely focus on Invisalign volume, scanner demand and whether the operational review produces stronger growth.

Align Technology Price Performance

Shares of NASDAQ ALGN opened at $180.08 on Thursday. The stock has a market capitalization of $12.90 billion, a PE ratio of 30.21, a P/E/G ratio of 1.80 and a beta of 1.67. Align Technology, Inc. has a one year low of $122.00 and a one year high of $207.08. The business’s fifty day moving average price is $174.24 and its 200-day moving average price is $175.25.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share for the quarter, topping the consensus estimate of $2.62 by $0.02. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.49 EPS. As a group, equities analysts expect that Align Technology, Inc. will post 9.48 EPS for the current fiscal year.

Align Technology declared that its board has authorized a share repurchase plan on Wednesday, April 29th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to purchase up to 1.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ALGN shares. Weiss Ratings raised Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. UBS Group restated a “neutral” rating and set a $189.00 price objective on shares of Align Technology in a report on Thursday, July 23rd. Zacks Research lowered shares of Align Technology from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 16th. BMO Capital Markets assumed coverage on shares of Align Technology in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $209.00 target price on the stock. Finally, Piper Sandler increased their target price on shares of Align Technology from $220.00 to $235.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, Align Technology has a consensus rating of “Moderate Buy” and a consensus target price of $206.36.

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.